Abiopharma

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Hercules Capital, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – HTGC

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

REX American Resources Reports Record High Full Fiscal Year 2025 Net Income Per Share Attributable to REX Common Shareholders of $2.50

Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATRA

Bridger Aerospace Names Justin Mogford as General Counsel, Further Strengthening Management Team

Luana Savings Bank Selects nCino to Unify and Transform Its Commercial and Agricultural Lending Operations

Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026

NMG and Government of Canada Execute Updated Binding Offtake and Marketing Framework for Matawinie Graphite

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçets Disease